David Nolen, MD
Facial Plastic Surgery · Austin, TXNPI 1427219278
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,722 of the $3,053 with a category attached, or 89.1%. 19 manufacturers reported payments, led by Sanofi at 26.1% of the total.
Across 68 payments — averaging $44.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$796
- Integra Lifesciences Corporation$706
- Regeneron Healthcare Solutions, Inc.$333
- Inspire Medical Systems, Inc.$202
- Olympus America Inc.$190
- Galderma Laboratories, L.p.$101
- plus $726 from 13 others
What the payments were for
- Food & beverage$2,72289%
- Education$261%
- Other$30610%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 23 | $796 |
| Integra Lifesciences Corporation | 8 | $706 |
| Regeneron Healthcare Solutions, Inc. | 8 | $333 |
| Inspire Medical Systems, Inc. | 3 | $202 |
| Olympus America Inc. | 2 | $190 |
| Galderma Laboratories, L.p. | 1 | $101 |
| AbbVie | 4 | $100 |
| Medtronic | 1 | $96 |
| Cochlear Americas | 1 | $92 |
| Aerin Medical Inc. | 2 | $70 |
| GSK | 3 | $64 |
| Acclarent, Inc | 2 | $54 |
| Hill Dermaceuticals, Inc. | 1 | $52 |
| Hikma Pharmaceuticals USA | 3 | $50 |
| Optinose US, Inc. | 2 | $45 |
| Acera Surgical, Inc. | 1 | $30 |
| Avita Medical Americas, LLC | 1 | $29 |
| Merck | 1 | $26 |
| Stryker | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,053 in reported general payments places this provider in the 70th percentile of 42 facial plastic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinolone Acetonide Oil | 16 | $519 |
| Fluticasone Propionate | 20 | $398 |
| Mupirocin | 24 | $201 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $142 |
| Cephalexin | 11 | $96 |
| Oxycodone Hcl | 35 | $96 |
| Ondansetron OdtOndansetron | 23 | $69 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Austin
- Edward BuckinghamAustin$15K
- Jeremy BarrAustin$793
- David TellerAustin$133
- Jose BarreraSan Antonio$120K
- Eli GordinDallas$52K
- Ifeolumipo SofolaThe Woodlands$49K
- Vu HoPlano$33K
- Tang HoHouston$4K
- Kent DavisHouston$4K
- Regina RodmanGalveston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.